pelvic%20inflammatory%20disease
PELVIC INFLAMMATORY DISEASE
Pelvic inflammatory disease (PID) is the ascent of bacteria from the vagina or cervix resulting in infection of the reproductive organs eg uterus, fallopian tubes, ovaries. It may also be a complication of sexually transmitted infections.
The most common symptoms of PID are lower abdominal pain (crampy or dull) that usually starts a few days after the onset of the last menstrual period, dyspareunia, abnormal vaginal or cervical discharge, postcoital or irregular vaginal bleeding, dysuria, fever, nausea and vomiting, although some have minimal symptoms or silent pelvic inflammatory disease.

Follow Up

  • Further review 4 wk after treatment may be useful to ensure the following:
    • Adequate clinical response
    • Compliance w/ oral antibiotics
    • Screening & treatment of sex partners/contacts
    • Recurrence prevention through condom use
  • Repeat testing for etiologic organisms may be warranted for patients w/ persistent symptoms, poor compliance w/ antibiotics, or possible reinfection
    • In patients w/ documented infection w/ C trachomatis N gonorrhoeae, some specialists recommend rescreening 4-6 wk after completion of treatment

Counselling

  • STI consultation allows for an opportunity to discuss patient’s risk factors for STIs & HIV
  • Determine patient’s risk for HIV & discuss HIV testing
  • Testing for HIV is recommended & should be offered to all persons seeking evaluation & treatment for STIs
    • Pretest & posttest counseling as well as informed consent are part of the testing procedure
    • Concomitant infection w/ HIV may complicate management & control of some STIs
    • HIV-infected patients w/ PID are more common to have tubo-ovarian abscess & usually require surgical intervention
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.